Zai Lab Limited, a biotechnology firm, declared that the National Medical Products Administration (NMPA) in China has endorsed the New Drug Application (NDA) for Augtyro (repotrectinib) for the therapy of grown-up patients with privately...
Sanofi, a leading pharmaceutical and healthcare firm, reports a venture of more than €1 billion to establish a new bioproduction limit at its locales in Vitry-sur-Seine (Val de Marne), Le Quality (Seine-Oceanic) and Lyon Gerland (Rhône)...
The US Food and Drug Administration has granted full clearance to Seagen Inc.'s Tivdak (tisotumab vedotin), which targets tissue factor (TF), for the treatment of patients with recurrent or metastatic cervical cancer who have progressed during or...
Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for Sevelamer Carbonate Tablets, 800 mg, from the USFDA
Intensity Therapeutics, Inc., a biotechnology firm, declares that the organization executed an alliance with The Swiss Group for Clinical Cancer Research (SAKK) to lead a stage 2 randomized (coordinated), controlled preliminary assessing clinical...
Mabwell Therapeutics, a biotechnology firm, reported that its self-created novel Nectin-4-focusing on ADC (Research and development code: 9MW2821) has been conceded Orphan Drug Designation (ODD) by the US FDA, for the therapy of esophageal...
Cipla, a renowned global pharmaceutical company, reported a high consolidated net profit growth of 79% to Rs. 932 crore in the fourth quarter ended March 2024, compared to Rs. 522 crore in the same time last year. Its earnings before tax and...
Keenness Drugs, Inc., a clinical-stage biopharmaceutical organization fostering a novel therapeutic that objectives harmful solvent amyloid beta oligomers (AßOs) for the treatment of Alzheimer's disease (AD), declared that the main patient has...
.jpg)
Recce Drugs Ltd, an organization growing a new class of synthetic anti-infectives intended to address the pressing worldwide medical conditions of anti-resistant safe superbugs and arising viral microbes, declared the China National Intellectual...
Arbor Biotechnologies, Inc., a biotechnology organization that finds and fosters the next generation of hereditary prescriptions, has reported the acquisition of Serendipity Biosciences, a confidential organization focused on the revelation of...
, CDSCO.jpg)
